Marijuana

A team of scientists has demonstrated a novel microencapsulation method designed to improve the absorption and bioavailability of CBD. Animal tests suggest the new method increases peak concentrations of CBD in the brain by 300% compared to CBD oil.

A study into the effects of cannabis on driving in a real-world context has found CBD alone does not impair driving ability. The landmark finding promises to be invaluable in guiding road safety regulations as cannabis laws shift across the globe.

A progressive wave of drug reforms have been passed by US voters, including four states legalizing recreational marijuana, one state decriminalizing natural psychedelics, and Oregon decriminalizing all drugs and legalizing psilocybin psychotherapy.

Some people find their symptoms of OCD dramatically drop after smoking cannabis, according to a new study. The improvements may only be beneficial in the short-term however, and more research is needed to understand the long-term effect of cannabis use on OCD.

Positive results from the world’s first clinical trial testing the potential for cannabidiol (CBD) to treat cannabis addiction suggest daily use of medical-grade CBD is both safe and effective at reducing problematic cannabis consumption.

New research is offering the first clinical trial insights into microdosing THC to treat chronic pain. The results of the small trial suggest tiny doses of THC may confer clinically apparent reductions in pain without inducing psychoactive effects.

A study has found smoking high-THC marijuana or concentrates does not result in greater levels of intoxication. The research adds weight to a body of evidence suggesting proposed roadside THC tests may not correlate with driving impairment.

With legal recreational cannabis use spreading across North America there is a debate over what the minimum age for consumption should be. A new study from Canadian researchers suggests 19 is the optimal age to set for recreational use of the drug.

Results from the world's first placebo-controlled clinical trial testing the efficacy of medicinal cannabis for chronic insomnia reveal statistically significant, and dose responsive, improvements to sleep quality using a novel CBD/THC formulation.

A study tracking the potency of cannabis products found most medical marijuana is stronger than it needs to be for pain relief. The research suggests high THC levels are unnecessary for medical uses and can increase the risk of negative side effects.

A team of researchers from King’s College London has, for the first time, imaged the brains of patients with psychosis under the influence of CBD. The study demonstrates the anti-psychotic potential of CBD, suggesting clinical trials are necessary.

A new study from a team of Brazilian scientists is reporting results from the first randomized, placebo-controlled clinical trial exploring the effect of cannabidiol (CBD) on anxiety, and anxiety-induced tremors, in Parkinson’s patients.